https://doi.org/10.3390/pharmaceutics14040714
M
Masaru Samura
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
369
Citations
11
h-index
11
i10-index
Masaru Samura is an academic researcher from Teikyo Heisei University. The author has contributed to research in topics: Antibiotics Pharmacokinetics and Efficacy & Antimicrobial Resistance in Staphylococcus & Bacterial Identification and Susceptibility Testing. The author has an h-index of 11, co-authored 28 publications.
ORCID: 0000-0002-8637-1237Papers by this author
worksEfficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis
2022 · Pharmaceutics · 20 citations
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
2023 · The Lancet Global Health · 12 citations
https://doi.org/10.1016/s2214-109x(23)00410-2
SARS-CoV-2 mRNA vaccine-related myocarditis and pericarditis: An analysis of the Japanese Adverse Drug Event Report database
2024 · Journal of Infection and Chemotherapy · 4 citations
https://doi.org/10.1016/j.jiac.2024.07.025
Development and validation of a population pharmacokinetic model of vancomycin for patients of advanced age
2025 · Journal of Pharmaceutical Health Care and Sciences · 0 citations
https://doi.org/10.1186/s40780-025-00423-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat